Formula 0 (PGE 20 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polar...

FDA Drug Recall #D-0807-2016 — Class II — March 14, 2016

Recall Summary

Recall Number D-0807-2016
Classification Class II — Moderate risk
Date Initiated March 14, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Meditech Laboratories, Inc
Location Las Vegas, NV
Product Type Drugs
Quantity 1320 vials - all formulas

Product Description

Formula 0 (PGE 20 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

Reason for Recall

Lack of Assurance of Sterility: incomplete or missing data regarding production.

Distribution Pattern

Nationwide

Lot / Code Information

Lot#: 020716-0, Exp 05/07/16

Other Recalls from Meditech Laboratories, Inc

Recall # Classification Product Date
D-0803-2016 Class II Formula 4 (Papaverine 18 mg, Phentolamine 2 mg,... Mar 14, 2016
D-0804-2016 Class II Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 ... Mar 14, 2016
D-0806-2016 Class II Formula 3 (Papaverine 20 mg, Phentolamine 3 mg,... Mar 14, 2016
D-0805-2016 Class II Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 ... Mar 14, 2016
D-0802-2016 Class II Formula 2 (Papaverine 9 mg, Phentolamine 1 mg, ... Mar 14, 2016

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.